http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014155074-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_712eaa4343402302c87d80c86c5350d1 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2014-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e89ccfb7c1dec2d946884b02ecf338 |
| publicationDate | 2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014155074-A1 |
| titleOfInvention | Composition |
| abstract | The present invention provides a topical composition comprising lidocaine wherein the pH of the composition is 6.5 to 7.5 and wherein 10 to less than 50 wt% of the lidocaine is in its base form. There is also provided such a compound for use in the treatment, prevention or alleviation of pain and/or inflammation. According to a further aspect, there is provided the compound for use in the treatment of a condition such as cystitis, proctitis, infections associated with wounds and/or the urinary bladder and premature ejaculation. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021201680-A1 |
| priorityDate | 2013-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.